Disease outcomes following lateral switch among different CD20-antibodies in active multiple sclerosis. Axhausen F, Mrochen A, Winter P, Baumgart R, et al. Mult Scler 2025 Jul 30:13524585251361330. doi: 10.1177/13524585251361330.

Read + Share

Amedeo Smart

Independent Medical Education

Axhausen F, Mrochen A, Winter P, Baumgart R, et al. Disease outcomes following lateral switch among different CD20-antibodies in active multiple sclerosis. Mult Scler 2025 Jul 30:13524585251361330. doi: 10.1177/13524585251361330.
PMID: 40735835